Skip to content
GLP-1 Scorecard
Menu
Graded #12

Found

The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

Visit Found ↗We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay
Tirzepatide
$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules
Coverage
All 50 states
Brand-name
Yes

Weigh Found against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value78/100
Dose & formulation94/100
Clinical oversight86/100
Labs & monitoring82/100
Fulfillment84/100
Contract terms70/100

Strengths

  • Widest medication list in this ranking — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
  • Flat pricing as the dose increases, so a titration does not raise the monthly cost
  • Bills insurance for the clinical visits — the site states most members pay under $30 per visit
  • Runs a dedicated GLP-1 microdose program for people who want a lower starting dose

Where it loses points

  • The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
  • Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
  • The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
  • Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are

Bottom line — Grade B

Best for: People who want insurance run against their clinical visits and a clinician free to move them between compounded, brand and oral routes.

Ranked #12 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Found — the realistic shortlist.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Found's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Found's site. Not medical advice; see our disclosure.

← Back to the scorecard